We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Urovant Sciences Ltd. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 41 → 0 (-41)

100% less capital invested

Capital invested by funds: $99.7M → $0 (-$99.7M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 41

Holders
–
Holders Change
-41
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
41
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$50.3M
2
BCM
Beryl Capital Management
California
-$5.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.51M
4
PCM
Prelude Capital Management
New York
-$3.99M
5
GF
Gabelli Funds
New York
-$3.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHS
26
Pekin Hardy Strauss
Illinois
– -$432K -26,768 Closed
GH
27
GAM Holding
Switzerland
– -$413K -25,600 Closed
BlackRock
28
BlackRock
New York
– -$398K -24,668 Closed
BFM
29
Boothbay Fund Management
New York
– -$363K -22,500 Closed
VEA
30
Virtus ETF Advisers
New York
– -$296K -18,324 Closed
CSS
31
Cubist Systematic Strategies
Connecticut
– -$287K -17,800 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$251K -15,550 Closed
SFI
33
Susquehanna Fundamental Investments
Pennsylvania
– -$245K -15,202 Closed
VF
34
Virtu Financial
New York
– -$239K -14,792 Closed
TI
35
Telemetry Investments
New York
– -$204K -12,633 Closed
Two Sigma Advisers
36
Two Sigma Advisers
New York
– -$195K -12,100 Closed
WAM
37
Wolverine Asset Management
Illinois
– -$71K -4,445 Closed
CFGS
38
Concourse Financial Group Securities
Alabama
– -$20K -1,250 Closed
TRCT
39
Tower Research Capital (TRC)
New York
– -$10K -638 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– -$5K -306 Closed
Wells Fargo
41
Wells Fargo
California
– -$5K -302 Closed
1
2

UROV Hedge Fund Activity: Q1 2021 in Review

0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q1 2021, worth a combined $0 — down 100% from $99.7M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of UROV and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $50.3M sold.

  • 0 institutional investors held Urovant Sciences Ltd. (UROV) as of Q1 2021, down from 41 in Q4 2020.
  • Funds reported $0 of Urovant Sciences Ltd. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Urovant Sciences Ltd. positions in Q1 2021 and 41 closed out, a net change of -41 holders.
  • The largest Urovant Sciences Ltd. seller in Q1 2021 was Perceptive Advisors, an estimated $50.3M sold.

Based on aggregated 13F filings for Q1 2021.